SPARTANBURG, S.C. (June 28, 2017)—J M Smith Corporation has named Saul Factor, RPh, as the new president of QS/1, effective July 1, 2017. Factor, who brings a wealth of experience and leadership in all areas of pharmacy, was selected in an international search after current president Tammy Devine announced her decision to retire after 35 years with the company earlier this year.

SOMERSET, N.J. (June 28, 2017)—Spring Hills Somerset Assisted Living has been recognized as a 2017 recipient of the Bronze Commitment to Quality Award for its dedication to improving the lives of residents through quality care. The distinction is one of three progressive award levels through the National Quality Award Program, presented by the American Health Care Association and National Center for Assisted Living (AHCA/NCAL), the leading association for long term and post-acute care.

Restoring dignity to those who experience hair loss can help with the healing process.

WATERLOO, Iowa (June 27, 2017)—Last week Rep. Jim McGovern (D-Mass.) introduced a bill that would provide coverage for wigs to Medicare beneficiaries. The bill, HR 2925 would allow wigs to be covered as durable medical equipment; opening access for Medicare beneficiaries that a dermatologist, oncologist or attending physician can certify medical necessity as a part of rehabilitative treatment.

Award grants opportunity to increase exports and research.

ATLANTA (June 26, 2017)—GF Health Products, Inc. (Graham-Field) is a recipient of a $5,000 grant and a semi-finalist in the annual Atlanta Metro Export Challenge (Atlanta MEC), a grant competition supported by JPMorgan Chase, UPS and Partnership Gwinnett, which boosts support for small and medium sized businesses looking to begin exporting or to increase their export programs.

The June 30 deadline for the Cures Act exemption for Group 3 power products is continued indefinitely.

WASHINGTON, D.C. (June 26, 2017)—The Centers for Medicare & Medicaid Services (CMS) today announced that accessories for Group 3 power Complex Rehab Technology (CRT) mobility products will continue to remain exempt from the application of competitive bidding derived pricing for Medicare beneficiaries.